StockData
aTYR PHARMA INC logo

aTYR PHARMA INC (ATYR) stock

ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.08−0.91 (-18.24%)

Close on Nov 18, 2026Market cap $400.20MP/E –Yield –

aTYR PHARMA total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

aTYR PHARMA's total debt was $3.06M at Sep 30, 2020. For fiscal 2019 it was $8.74M, down 45.5% from the year before. The highest annual figure on record is $19.73M in fiscal 2017.

Annual total debt

PeriodPeriod endValueChange
FY2019Dec 31, 2019$8.74M-45.5%
FY2018Dec 31, 2018$16.03M-18.8%
FY2017Dec 31, 2017$19.73M+106.9%
FY2016Dec 31, 2016$9.54M+85.5%
FY2015Dec 31, 2015$5.14M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2020Sep 30, 2020$3.06M-71.1%
Q2 FY2020Jun 30, 2020$4.98M-59.9%
Q1 FY2020Mar 31, 2020$6.87M-51.8%
Q4 FY2019Dec 31, 2019$8.74M-45.5%
Q3 FY2019Sep 30, 2019$10.59M-40.6%
Q2 FY2019Jun 30, 2019$12.42M-36.5%
Q1 FY2019Mar 31, 2019$14.23M-28.8%
Q4 FY2018Dec 31, 2018$16.03M-18.8%
Q3 FY2018Sep 30, 2018$17.81M+20.8%
Q2 FY2018Jun 30, 2018$19.57M+34.2%
Q1 FY2018Mar 31, 2018$19.98M+108.7%
Q4 FY2017Dec 31, 2017$19.73M+106.9%
Q3 FY2017Sep 30, 2017$14.75M–
Q2 FY2017Jun 30, 2017$14.58M–
Q1 FY2017Mar 31, 2017$9.57M–
Q4 FY2016Dec 31, 2016$9.54M–

More aTYR PHARMA figures

See a number that looks wrong?